Alpheus Medical raises $16m funding for non-invasive sonodynamic drug-device therapy
The funding will be used by the firm to conduct a first-in-human (FIH) clinical trial with its non-invasive…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
18 Nov 21
The funding will be used by the firm to conduct a first-in-human (FIH) clinical trial with its non-invasive…
12 Nov 21
The partnership makes NatureQuant’s NatureScoreTM technology available to researchers through Ksana Health’s Effortless Assessment Research System (EARS), an…
19 Oct 21
To validate its device’s capability to detect early neurocognitive impairments, Altoida will assess its software and digital biomarker…
08 Sep 21
Mayo Clinic researchers developed a set of paradigms, or viewpoints, that simplify comparisons between effects of electrical stimulation…
27 Aug 21
The COMMAND study will assess the safety and efficacy of the Stentrode in six severely paralysed patients in…
24 Aug 21
Rilaxta VRx, which is Cynergi’s software, will be used in combination with other treatments provided at NeuPath, as…
24 Aug 21
The new RF generator will be developed for use with NeuroOne's combination recording and ablation electrode, which enables…
21 Jul 21
The funds will be used to conduct the SANS-UUI pivotal clinical study of miniaturised implantable neuromodulation technology platform
07 Jul 21
The funds will be utilised to advance the development of its platform to rapidly meet the requirement for…
16 Jun 21
aura6000 is developed to treat adult patients with moderate to severe obstructive sleep apnea